ANALYSIS OF TIME TO FAILURE AFTER RETINAL DETACHMENT SURGERY.
Journal
Retina (Philadelphia, Pa.)
ISSN: 1539-2864
Titre abrégé: Retina
Pays: United States
ID NLM: 8309919
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
pubmed:
19
12
2019
medline:
11
9
2021
entrez:
19
12
2019
Statut:
ppublish
Résumé
To present the distribution of time to retinal redetachment in eyes undergoing retinal detachment surgery, using a method for adjusting time to outcome in eyes with silicone oil or heavy liquid tamponade ("oil-filled eyes"). Data from two Australian centers were used. Adjusted time to outcome was measured from the date of tamponade removal in oil-filled eyes, unless failure was diagnosed with tamponade in situ. 188/1257 failures were identified (15.0%). Using unadjusted time to outcome, failures in oil-filled eyes occurred later than non-oil-filled eyes (median time to failure 57 vs. 28 days, P < 0.001). After adjustment, the distribution of time to failure was similar for oil-filled and non-oil-filled eyes (median 25 vs. 28 days, P = 0.68). Larger detachments, eyes with ≥Grade B proliferative vitreoretinopathy and eyes receiving surgery for recurrent detachments were more likely to fail, but the time to failure was similar regardless of risk. Adjustment of time to outcome resulted in a similar distribution of time to failure in oil-filled and non-oil filled eyes and was similar in low- and high-risk eyes. The use of adjusted time to outcome will support consistent collection and interpretation of outcomes across different jurisdictions where time to oil removal may vary.
Identifiants
pubmed: 31851051
doi: 10.1097/IAE.0000000000002715
pii: 00006982-202010000-00007
doi:
Substances chimiques
Silicone Oils
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1909-1917Références
Pokhrel PK, Loftus SA. Ocular emergencies. Am Fam Physician 2007;76:829–836.
Go SL, Hoyng CB, Klaver CC. Genetic risk of rhegmatogenous retinal detachment: a familial aggregation study. Arch Ophthalmol 2005;123:1237–1241.
Williamson TH, Lee EJ, Shunmugam M. Characteristics of rhegmatogenous retinal detachment and their relationship to success rates of surgery. Retina 2014;34:1421–1427.
Day S, Grossman DS, Mruthyunjaya P, et al. One-year outcomes after retinal detachment surgery among medicare beneficiaries. Am J Ophthalmol 2010;150:338–345.
Ah-Fat FG, Sharma MC, Majid MA, et al. Trends in vitreoretinal surgery at a tertiary referral centre: 1987 to 1996. Br J Ophthalmol 1999;83:396–398.
Thompson JA, Snead MP, Billington BM, et al. National audit of the outcome of primary surgery for rhegmatogenous retinal detachment. II. Clinical outcomes. Eye (Lond) 2002;16:771–777.
Mitry D, Awan MA, Borooah S, et al. Surgical outcome and risk stratification for primary retinal detachment repair: results from the Scottish Retinal Detachment study. Br J Ophthalmol 2012;96:730–734.
Sallam AB, Donachie PHJ, Yorston D, et al. Royal college of ophthalmologist's national database study of vitreoretinal surgery: report 7, intersurgeon variations in primary rhegmatogenous retinal detachment failure. Retina 2018;38:334–342.
Banerjee PJ, Quartilho A, Bunce C, et al. Slow-release dexamethasone in proliferative vitreoretinopathy: a prospective, randomized controlled clinical trial. Ophthalmol 2017;124:757–767.
Wickham L, Ho-Yen GO, Bunce C, et al. Surgical failure following primary retinal detachment surgery by vitrectomy: risk factors and functional outcomes. Br J Ophthalmol 2011;95:1234–1238.
Azen SP, Boone DC, Barlow W, et al. Methods, statistical features, and baseline results of a standardized, multicentered ophthalmologic surgical trial: the Silicone Study. Control Clin Trials 1991;12:438–455.
The Silicon Oil Study Group. Vitrectomy with silicon oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomised control trial. Arch Ophthalmol 1992;110:780–792.
Heimann H, Hellmich M, Bornfeld N, et al. Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment (SPR Study): design issues and implications. Graefes Arch Clin Exp Ophthalmol 2001;239:567–574.
Lee E, Housseini ZE, Steel DHW, Williamson TH. An analysis of the outcomes for patients with failed primary vitrectomy for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol 2014;252:1711–1716.
Goezinne F, La Heij EC, Berendschot TT, et al. Incidence of redetachment 6 months after scleral buckling surgery. Acta Ophthalmol 2010;88:199–206.
Mazinani B, Baumgarten S, Schiller P, et al.; VIPER Study Group. Vitrectomy with or without encircling band for pseudophakic retinal detachment: a multi-centre, three-arm, randomised clinical trial. VIPER Study Report No. 1—design and enrolment. Br J Ophthalmol 2016;100:405–410.
Banerjee PJ, Cornelius VR, Phillips R, et al. Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trial. Trials 2016;22:339.
Charteris DG, Aylward GW, Wong D, et al.; PVR Study Group. A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmol 2004;111:2240–2245.
Tornambe PE, Hilton GF. Pneumatic retinopexy. A multicenter randomized controlled clinical trial comparing pneumatic retinopexy with scleral buckling. The Retinal Detachment Study Group. Ophthalmology 1989;96:772–783.
Heimann H, Bartz-Schmidt KU, Bornfeld N, et al.; Scleral Buckling versus Primary Vitrectomy in Rhegmatogenous Retinal Detachment Study Group. Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: a prospective randomized multicenter clinical study. Ophthalmol 2007;114:2142–2154.
Joussen AM, Kirchhof B, Schrage N, et al.; HSO Study Group. Heavy silicone oil versus standard silicone oil as vitreous tamponade in inferior PVR (HSO Study): design issues and implications. Acta Ophthalmol Scand 2007;85:623–630.
Tornambe PE, Hilton GF, Brinton DA, et al. Pneumatic retinopexy. A two-year follow-up study of the multicenter clinical trial comparing pneumatic retinopexy with scleral buckling. Ophthalmol 1991;98:1115–1123.
Scott IU, Flynn HW Jr, Murray TG, Feuer WJ; Perfluoron study group. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicentre study. Am J Ophthalmol 2003;136:454–463.
Foster RE, Meyers SM. Recurrent retinal detachment more than 1 year after reattachment. Ophthalmol 2002;109:1821–1827.
Scholda C, Egger S, Lakits A, et al. Retinal detachment after silicone oil removal. Acta Ophthalmol Scand 2000;78:182–186.
Falkner CI, Binder S, Kruger A. Outcome after silicone oil removal. Br J Ophthalmol 2001;85:1324–1327.
Falkner-Radler CI, Smretschnig E, Graf A, Binder S. Outcome after silicone oil removal and simultaneous 360° endolaser treatment. Acta Ophthalmol 2011;89:e46–51.
Jonas JB, Budde WM, Knorr HL. Timing of retinal redetachment after removal of intraocular silicone oil tamponade. Am J Ophthalmol 1999;128:628–631.
Goezinne F, La Heij EC, Berendschot TT, et al. Risk factors for redetachment and worse visual outcome after silicone oil removal in eyes with complicated retinal detachment. Eur J Ophthalmol 2007;17:627–637.
Enders P, Schick T, Schaub F, et al. Risk of multiple recurring retinal detachment after primary rhegmatogenous retinal detachment repair. Retina 2017;37:930–935.